KROS R&D Expenses
Keros Therapeutics Inc · R&D Expenses
KROS R&D Expenses
Latest reported$75.86Mperiod ending
KROS R&D Expenses ($10.11M → $75.86M)
Annual R&D Expenses
High-resolution chart · PNG
KROS r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 129,643,000 | |
| 173,629,000 | |
| 135,258,000 | |
| 87,265,000 | |
| 55,143,000 | |
| 33,860,000 | |
| 17,379,000 | |
| 10,111,000 |